EphB1 causes retinal damage through inflammatory pathways in the retina and retinal Müller cells

Li Liu1, Youde Jiang1, Mohamed Al-Shabrawey2,3

  • 1Department of Ophthalmology, Visual and Anatomical Sciences, Wayne State University School of Medicine, Detroit, MI.

Molecular Vision
|April 11, 2024
PubMed
Abstract

Insights

Increased ephrin type-B receptor 1 (EphB1) in diabetic retinas promotes inflammation and damage. Inhibiting EphB1 may be a new treatment for diabetic retinopathy.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Diabetic Complications

Background:

  • Diabetic retinopathy is a leading cause of vision loss.
  • Inflammation plays a critical role in diabetic retinopathy pathogenesis.
  • The role of ephrin type-B receptor 1 (EphB1) in diabetic retinal inflammation is not fully understood.

Purpose of the Study:

  • To investigate the role of EphB1 in diabetic retinal inflammation.
  • To determine if elevated EphB1 levels contribute to inflammatory mediator production in Müller cells.
  • To assess the impact of EphB1 on retinal damage in response to ischemia/reperfusion (I/R).

Main Methods:

  • Analyzed EphB1 protein levels in human and mouse diabetic retinas.
  • Utilized cultured rat Müller cells (rMC-1) treated with EphB1 siRNA or ephrin B1-Fc under high glucose conditions.
  • Employed adeno-associated virus (AAV) to overexpress EphB1 in Müller cells in vivo.
  • Induced I/R in mice treated with EphB1-overexpressing AAV to evaluate retinal neuronal changes.

Main Results:

  • EphB1 protein levels were elevated in diabetic retinas and high glucose-treated Müller cells.
  • Knockdown of EphB1 decreased inflammatory mediators in Müller cells.
  • Ephrin B1-Fc treatment increased inflammatory proteins in Müller cells.
  • EphB1 overexpression exacerbated retinal thinning and neuronal cell loss following I/R.

Conclusions:

  • Elevated EphB1 in diabetic retinas contributes to inflammation and Müller cell activation.
  • EphB1 exacerbates retinal damage in models of I/R injury.
  • Targeting EphB1 presents a potential therapeutic strategy for diabetic retinopathy.

Related Concept Videos

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
6.0K